Icon

ABSORICA (nda021951)- (10MG,20MG,25MG,30MG,35MG,40MG)

ISOTRETINOIN SUN PHARM INDS INC
10MG,20MG,25MG,30MG,35MG,40MG
Yes Yes
2021-Sep-21 Expired
None 2015-May-25
None No
ABSORICA is retinoids indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater. Because of significant adverse reactions associated with its use, ABSORICA is reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics.
4 0 4
Total Other Developers 19
Drugs with Suitability No
10MG ** ** - - 2
20MG ** ** - - 2
25MG ** ** - - 1
30MG ** ** - - 3
35MG ** ** - - -
40MG ** ** - - 2
NDA Sales Available Total Generic Sales Available
Yes 3
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ********* ****** *** ********** ******* *********** ****-**, **** **.**, *****, *.*.***, ******** *******, ********* ******, ******** ********, ********, ****** ******* ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.